What is Elafin?

A 57-amino-acid natural protease inhibitor; tiprelestat is a recombinant form studied in surgery-related inflammation.

Elafin in the library · · Human Trials · What are peptides?

2 registered trials · 17 indexed papers · 30 human / 1 animal studies

From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.

What it is

A 57-amino-acid natural protease inhibitor; tiprelestat is a recombinant form studied in surgery-related inflammation.

Type: Peptide.

Definition (National Library of Medicine)

“A secretory proteinase inhibitory protein that was initially purified from human skin. It is found in a variety mucosal secretions and is present at high levels in sputum. Elafin may play a role in the innate immunity (immunity, innate) response of the lung.”

  • MeSH: Elafin

Human research

The registered human trials and peer-reviewed human studies linked below are listed from ClinicalTrials.gov and PubMed. A study is linked only when Elafin is one of its interventions, or is named in the study title or subject headings.

Listing a study does not mean it showed a benefit, and it is not medical advice.

Registered human trials (2)

Peer-reviewed studies (17)

PaperAuthorsJournalYearType
Association of inflammation-related markers and diabetic retinopathy severity in the aqueous humor, but not serum of type 2 diabetic patientsSaucedo L et al.PloS one2023Observational Study
Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin DeficiencySweatt AJ et al.Chest2021Observational Study
Cervicovaginal natural antimicrobial expression in pregnancy and association with spontaneous preterm birthHezelgrave NL et al.Scientific reports2020Observational Study
Upregulation of elafin expression in the fallopian tube of ectopic tubal pregnancies compared to the normal tubesZakizadeh F et al.Journal of reproductive immunology2020Observational Study
Peptidase inhibitor 3 and chemokine ligand 27 may serve as biomarkers for actinic keratoses in organ transplant recipientsGeusau A et al.European journal of dermatology : EJD2019Randomized Controlled Trial
Dysregulation in Genital Tract Soluble Immune Mediators in Postmenopausal Women Is Distinct by HIV StatusGhosh M et al.AIDS research and human retroviruses2019Observational Study
Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgeryAlam SR et al.Journal of cardiothoracic surgery2017Randomized Controlled Trial
Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantationNomura S et al.Transplant immunology2017Clinical Trial
Plasma Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome: A Multicenter Survival and Longitudinal Prospective Observation StudyWang T et al.Shock (Augusta, Ga.)2017Observational Study
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and BevacizumabBasho RK et al.JAMA oncology2017Clinical Trial, Phase I
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitisKhattri S et al.Experimental dermatology2017Randomized Controlled Trial
Neither vaginal nor buccal administration of [amount hidden] misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot studyKalams SA et al.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception2016Clinical Trial
Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trialAlam SR et al.Heart (British Cardiac Society)2015Randomized Controlled Trial
Cervical Expression of Elafin and SLPI in Pregnancy and Their Association With Preterm LaborItaoka N et al.American journal of reproductive immunology (New York, N.Y. : 1989)2015Clinical Trial
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responsesYin F et al.Stem cells (Dayton, Ohio)2014Clinical Trial, Phase I
Elafin expression in mucosa of fallopian tubes is altered by hydrosalpinxNeto EP et al.Reproductive sciences (Thousand Oaks, Calif.)2014Randomized Controlled Trial
Changes in vaginal morphology, steroid receptor and natural antimicrobial content following treatment with low-dose mifepristoneNarvekar N et al.Contraception2007Clinical Trial

Conditions researched

Related compounds

FAQ

What is Elafin?

A 57-amino-acid natural protease inhibitor; tiprelestat is a recombinant form studied in surgery-related inflammation.

How many registered human trials study Elafin?

The PeptideWhiz trial index lists 2 registered trials for Elafin, the most recent from 2026.

How much published research exists on Elafin?

The PeptideWhiz paper index links 17 PubMed papers to Elafin; by study type, 30 human and 1 animal studies.

Which conditions is Elafin researched for?

Atherosclerosis, cardiovascular disease & high blood pressure, Chronic and systemic inflammation, Diabetic retinopathy and glaucoma, Eczema, Immune system (general), Lung health, asthma & COPD, Post-surgical inflammation and surgery recovery, Pregnancy and breastfeeding: safety notes.

Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).